These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23098406)

  • 1. [How to prolong life of patients at high cardiovascular risk. Features of rosuvastatin].
    Drapkina OM; Korneeva ON
    Kardiologiia; 2012; 52(8):89-92. PubMed ID: 23098406
    [No Abstract]   [Full Text] [Related]  

  • 2. The Post-JUPITER trial era and the cost of preventive medicine.
    Papadopoulos VP
    Hellenic J Cardiol; 2010; 51(2):187-8. PubMed ID: 20378525
    [No Abstract]   [Full Text] [Related]  

  • 3. Is Jupiter also a god of primary prevention?
    Accad M; Fred HL
    Tex Heart Inst J; 2010; 37(1):6-7. PubMed ID: 20200621
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rosuvastatin has no effect on clinical outcomes in patients with heart failure. Results of the GISSI-HF trial].
    Preorazhenskiĭ DV
    Kardiologiia; 2009; 49(4):64-5. PubMed ID: 19463122
    [No Abstract]   [Full Text] [Related]  

  • 5. Rosuvastatin in patients with elevated C-reactive protein.
    Davis CE
    N Engl J Med; 2009 Mar; 360(10):1040; author reply 1041-2. PubMed ID: 19271278
    [No Abstract]   [Full Text] [Related]  

  • 6. Rosuvastatin in patients undergoing hemodialysis.
    Kassimatis TI; Konstantinopoulos PA
    N Engl J Med; 2009 Jul; 361(1):93; author reply 94-5. PubMed ID: 19579277
    [No Abstract]   [Full Text] [Related]  

  • 7. Rosuvastatin in patients undergoing hemodialysis.
    de Oliveira JM
    N Engl J Med; 2009 Jul; 361(1):93-4; author reply 94-5. PubMed ID: 19579278
    [No Abstract]   [Full Text] [Related]  

  • 8. Rosuvastatin outcomes study JUPITER closes early due to evidence of benefit.
    Cardiovasc J Afr; 2008; 19(2):117. PubMed ID: 18516361
    [No Abstract]   [Full Text] [Related]  

  • 9. [Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)].
    Mareev VIu
    Kardiologiia; 2008; 48(1):74-5. PubMed ID: 18261000
    [No Abstract]   [Full Text] [Related]  

  • 10. Rosuvastatin in patients with elevated C-reactive protein.
    Jenny-Avital ER
    N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271275
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA approves a statin therapy for some: certain, asymptomatic individuals targeted.
    Mitka M
    JAMA; 2010 Apr; 303(13):1242-3. PubMed ID: 20371776
    [No Abstract]   [Full Text] [Related]  

  • 12. Rosuvastatin in patients with elevated C-reactive protein.
    Koller MT; Bucher HC; Steyerberg EW
    N Engl J Med; 2009 Mar; 360(10):1041; author reply 1041-2. PubMed ID: 19271276
    [No Abstract]   [Full Text] [Related]  

  • 13. Rosuvastatin and primary cardiovascular prevention. Continue to use pravastatin or simvastatin.
    Prescrire Int; 2011 Apr; 20(115):94. PubMed ID: 21648210
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulatory divergence.
    Breckenridge A
    Clin Trials; 2011 Aug; 8(4):425-6; discussion 430-1. PubMed ID: 21835859
    [No Abstract]   [Full Text] [Related]  

  • 15. Rosuvastatin in patients with elevated C-reactive protein.
    Chan PS; Nallamothu BK; Hayward RA
    N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271273
    [No Abstract]   [Full Text] [Related]  

  • 16. Translating study results to labeling.
    Temple R
    Clin Trials; 2011 Aug; 8(4):427-9; discussion 430-1. PubMed ID: 21835860
    [No Abstract]   [Full Text] [Related]  

  • 17. A tale of five opinions (at least).
    Day S
    Clin Trials; 2011 Aug; 8(4):423-4; discussion 430-1. PubMed ID: 21835858
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trial update II: Jupiter trial, rosuvastatin has greater efficacy in elderly populations.
    Fricker J
    Eur Heart J; 2009 Dec; 30(23):2821. PubMed ID: 19972644
    [No Abstract]   [Full Text] [Related]  

  • 19. From CARDS to AURORA: one disease, two responses.
    Escobar C; Barrios V; Echarri R
    Hellenic J Cardiol; 2010; 51(3):281. PubMed ID: 20515865
    [No Abstract]   [Full Text] [Related]  

  • 20. [Statin cuts cardiovascular risk in half].
    Einecke D
    MMW Fortschr Med; 2008 Dec; 150(49-50):12-3. PubMed ID: 19133364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.